Click here to read the articles and view the interactive digital edition
Pharma Pulse 6/20/25: Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns
How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress
A cross-sectional study investigates whether becoming eligible for Medicare at age 65 is linked to changes in healthcare use among individuals experiencing mental health challenges.
Establishing Additional Transparency
In the third part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, explains how a flat admin fee model can potentially create more value for both payers and patients.
Pharma Pulse 6/19/25: Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research
The Impact of Initial Coverage Choice
Is Medicare plan switching influenced by initial type of Medicare coverage and cancer history?
TekniPlex Healthcare Unveils New Barrier Protection Systems Plant
The 200,000 square-foot Madison, WI facility will serve as the flagship location, with capabilities for future growth.
The Art of Agility
The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.
Moving Beyond the Rebate-Driven Model
In the second part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, discusses how this MFN executive order can affect players in the space that operate under a rebate-driven PBM model.
Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges
Bolstering Health Technology Assessment With the Help of AI
Ways to address limitations while also enhancing the decision-making process.
Changing the PAP Model
The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.
United States, United Kingdom Reach Tariff-Lowering Deal
Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% tax on imports.
Building Intelligent Pharma Supply Chain Management with Real-World Data
Approaches powered by RWD can clear the way for a greater focus on patient-centered care.
Analysis of the MFN Executive Order
In the first part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, outlines the most critical root causes of rising healthcare and drug costs that the MFN executive order doesn’t address.
Pharma Pulse 6/17/25: How AI and Regulation are Reshaping the Future of Drug Safety; A Reflection on Our Path Forward
Policy Whiplash? 24 Hours in the Hub Still Matters More
Doubling down on patient access and support fundamentals will win out over Washington’s next move.
Raising the Alarm
Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.
UCB to Invest $5 Billion into US Production Plant
The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.
Financial Assistance: Matching Awareness With Action
Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.
How Regulatory Mandates Influence Technology
In the third part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, shares the ways in which regulations, including DSCSA, are impacting the adoption of smarter packaging technologies across the industry.
Pharma Pulse 6/16/25: What Actually Moves the Needle on Inclusive Research; The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
Addressing the Threat of Prescription Abandonment
As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?
Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble
An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.
Reviewing the Most-Favored Nation Model
How practical is this form of pricing in the pharma setting?
Embedded Product Intelligence’s Role in Maintaining Cold Chain Integrity
In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.